Jennison's Q4 2025 Portfolio Is a Mega-Cap Stack: Top 10 Names Control 47.6% of $166.57B
Jennison Associates finished Q4 2025 at $166.57B, led by NVDA at $14.56B. With top-10 concentration at 47.6%, the filing shows high-conviction mega-cap growth positioning with selective breadth.
Jennison Associates ended Q4 2025 with $166.57B in canonical 13F AUM, and the portfolio reads like a concentrated mega-cap growth stack. The top 10 holdings account for 47.6% of disclosed weight, led by NVIDIA (NVDA) at $14.56B.
TL;DR
- Canonical AUM: $166.57B in 2025Q4.
- Current positions: 500 in the generated holdings output.
- Largest holding: NVDA at 8.74% ($14.56B).
- Concentration: Top-5 at 31.3%, top-10 at 47.6%.
- Core basket: NVDA, MSFT, AMZN, AAPL, and AVGO.
- AUM trend: $171.77B in 2025Q3 down to $166.57B in 2025Q4 (-3.0%), after a strong rebound in Q2.
- Interpretation: High-conviction growth remains intact despite quarter-to-quarter AUM volatility.
Filing Snapshot
Jennison’s generated brief reports $166.57B canonical AUM, $166.52B holdings value sum, and WhaleScore of 73.25. Position sizing in the top cohort reflects conviction in platform tech and AI-linked franchises, with less emphasis on equal-weight risk distribution.
Top Holdings: Conviction in the Growth Leaders
NVDA, MSFT, AMZN, AAPL, and AVGO make up the top disclosed stack and push top-5 concentration above 30%. Add GOOGL, LLY, and META, and the portfolio’s direction remains clearly tilted toward large-cap growth franchises with substantial earnings momentum profiles.
JENNISON ASSOCIATES LLC Top Holdings — 2025Q4 ($B)
This concentration level is not extreme single-name risk, but it is materially more directional than broad-index style portfolios. It tells readers that stock selection in the first decile of names likely drives most quarter outcomes.
AUM Volatility: Drawdown, Rebound, Then Stabilization
The AUM path shows a visible dip in 2025Q1 ($142.58B), a strong snapback in 2025Q2 ($168.61B), further growth in Q3, and a modest pullback in Q4. Net-net, scale remains high and close to prior peaks, while concentration in growth leaders is preserved.
JENNISON ASSOCIATES LLC AUM History
What Investors Should Watch Next
If this concentration profile persists, the next quarter’s relative performance signal will likely hinge on leadership behavior in semiconductors, hyperscaler software, and large-cap internet. Tracking changes in top-10 mix may matter more than incremental tail-position churn.
Important Interpretation Caveat
The API can surface many lines as “NEW position” for large filers. In this analysis, that label is treated as a possible artifact; value, weight, and concentration statistics are the primary evidence base.
Q&A
What is Jennison Associates’ AUM in Q4 2025?
The canonical 13F AUM is $166.57B for 2025Q4 in the generated research brief.
How concentrated is Jennison in Q4 2025?
Top-5 concentration is 31.3% and top-10 concentration is 47.6%, indicating a high-conviction top-book structure.
Which stock is Jennison’s largest disclosed position?
NVDA at $14.56B and 8.74% portfolio weight.
Did Jennison’s AUM rise or fall in Q4 2025?
AUM fell from $171.77B in 2025Q3 to $166.57B in 2025Q4, a -3.0% QoQ move in the AUM history chart data.
Where can I track these names on 13F Insight?
Monitor Jennison and top holdings pages including NVDA, MSFT, AMZN, and AAPL.
Related Research
Explore all researchUBS Asset Management's $472.97B portfolio reveals aggressive mega-cap tech concentration with NVDA at 8.13% weight, a $2.2B real estate exit from PLD and EQIX, and a staggering +1,064% increase in Netflix shares.
Mar 30, 2026
CalPERS' latest 13F reveals $174.90B in reported AUM with VOO at 11.89% — nearly $20B in one S&P 500 ETF. Combined with NVDA at 8.55%, the top-2 holdings account for 20.44% of this pension giant's portfolio.
Mar 30, 2026
IMC-Chicago filed a $275.42B Q4 2025 13F showing 84 new positions, 84 exits, and a book dominated by ETF, index, and derivative-style exposures.
Mar 29, 2026
Simplex Trading reported a $177.41B Q4 2025 13F, but the filing reads less like a stock portfolio and more like an options-heavy market-structure book. That distinction is the whole story.
Apr 1, 2026
Janus Henderson (WhaleScore 75.50) opened 67 new positions while exiting 67 in Q4 2025 — a 13.4% turnover rate signaling active repositioning. New biotech/med-device bets (ISRG, GPCR, PTGX) hint at a healthcare conviction thesis.
Mar 30, 2026